LISATA THERAPEUTICS INC (LSTA)
US1280583022 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.94M | 22.49M 25.36% | 32.797M -100.00% | 2.72M | 3.672M | 46.92M 1,177.78% | 132.6M 182.61% | 249.9M 88.46% | |||||||||||
| EBITDA YoY % growth | -55.55M | -48.89M 11.99% | N/A 40.58% | N/A 6.30% | -17.34M 38.43% | N/A -19.45% | -19.686M 4.65% | -31.008M -51.86% | -60.486M -98.45% | -28.152M 55.64% | -24.684M 3.27% | -27.438M -11.16% | -31.518M -14.87% | -36.312M -15.21% | -33.66M 7.30% | N/A | N/A | N/A | |
| EBIT YoY % growth | -57.74M | -51.58M 10.67% | -32.696M 42.81% | -27.424M 6.47% | -17.952M 38.42% | -20.37M -18.25% | -20.289M 4.68% | -30.86M -51.70% | -60.486M -98.28% | -28.684M 55.37% | -25.574M 0.52% | -27.992M -9.45% | -31.518M -12.59% | -47.226M -49.84% | -47.43M -0.43% | -43.86M 7.53% | -29.58M 32.56% | 111.18M 475.86% | |
| Operating Margin | -321.85% | -229.35% | -99.69% | N/A | N/A | N/A | N/A | N/A | -2,223.75% | N/A | N/A | N/A | N/A | N/A | -1,291.67% | -93.48% | -22.31% | 44.49% | |
| EPS YoY % growth | -253.50 | -222.00 12.43% | -77.34 64.53% | -32.28 59.43% | -26.78 15.02% | -26.62 -3.31% | -12.47 75.94% | -8.31 -15.56% | -10.23 -45.38% | -2.87 77.25% | -2.78 -7.73% | -2.40 13.58% | -1.36 43.52% | -1.44 -6.02% | -1.29 10.64% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.86 -30.59% | -0.75 -16.12% | -0.62 -2.00% | -0.80 -34.85% | -0.77 11.24% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | -6.834M -17.10% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.049M -17.00% | -7.352M -11.38% | -6.138M -11.14% | -7.66M -43.56% | -7.396M -4.92% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.59 9.23% | -0.77 | 0.18 | 22.88% |
| Q2 2024 Q2Q % growth | -0.61 -22.00% | -0.78 | 0.17 | 21.31% |
| Q1 2024 Q2Q % growth | -0.65 15.58% | -0.74 | 0.09 | 12.10% |
| Q4 2023 Q2Q % growth | -0.66 13.16% | -0.91 | 0.25 | 27.30% |
| Q3 2023 Q2Q % growth | -0.65 91.75% | -0.95 | 0.30 | 31.48% |
| Q2 2023 Q2Q % growth | -0.50 69.70% | -0.71 | 0.21 | 29.97% |
| Q1 2023 Q2Q % growth | -0.77 26.67% | -0.83 | 0.06 | 6.80% |
| Q4 2022 Q2Q % growth | -0.76 53.94% | -1.03 | 0.27 | 26.23% |
| Q3 2022 Q2Q % growth | -7.88 -337.78% | -0.92 | -6.96 | -758.39% |
| Q2 2022 Q2Q % growth | -1.65 -10.00% | -1.48 | -0.17 | -11.56% |
| Q1 2022 Q2Q % growth | -1.05 63.16% | -1.48 | 0.43 | 29.01% |
| Q4 2021 Q2Q % growth | -1.65 60.71% | -2.22 | 0.57 | 25.63% |
| Q3 2021 Q2Q % growth | -1.80 58.62% | -2.30 | 0.49 | 21.57% |
| Q2 2021 Q2Q % growth | -1.50 -120.00% | -2.22 | 0.72 | 32.39% |
| Q1 2021 Q2Q % growth | -2.85 50.00% | -1.30 | -1.55 | -119.15% |
| Q4 2020 Q2Q % growth | -4.20 40.43% | -3.88 | -0.32 | -8.36% |
| Q3 2020 Q2Q % growth | -4.35 38.30% | -4.44 | 0.09 | 1.96% |
| Q2 2020 Q2Q % growth | 7.50 202.04% | -5.93 | 13.43 | 226.50% |
| Q1 2020 Q2Q % growth | -5.70 13.64% | -4.44 | -1.26 | -28.47% |
| Q4 2019 Q2Q % growth | -7.05 | -5.28 | -1.77 | -33.56% |
| Q3 2019 Q2Q % growth | -7.05 | -6.58 | -0.47 | -7.16% |
| Q2 2019 Q2Q % growth | -7.35 | -6.81 | -0.54 | -7.95% |
| Q1 2019 Q2Q % growth | -6.60 | -6.50 | -0.10 | -1.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2021 Q2Q % growth | 467.843K | -467.843K | -100.00% | |
| Q1 2021 Q2Q % growth | 672.18K | -672.18K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -0.6% | 6.03% | 8.86% |
| Revenue | N/A | N/A | N/A | N/A |